RICOVR’s patented testing platform leverages the first truly portable nanoparticle detection technology, allowing for fast, non- invasive specimen collection and analytics. With the collaboration of industry experts, the company’s platform is versatile and already expanding into new testing diagnostics including COVID-19, additional drug panels, and critical disease testing.

RICOVR is driven by the belief that a more accurate and cost-effective solution should be  available for employers, law enforcement, healthcare systems and others relying on fast and reliable access to data.

RICOVR team includes experts across medical device design and manufacturing, leadership, sales, medicine, technology, and scientific research to deliver on your needs today and tomorrow.

MANAGEMENT TEAM

DR. HIMANSHU BHATIA FOUNDER & CEO

PIYUSH SADANA CO-FOUNDER & COO

KYLE MUSE CMO

BRETT FELMEY VICE PRESIDENT – SALES

ADVISORY BOARD

SURYA MOHAPATRA

BEN BALDANZA

KEVIN QUINN

* Product details and images are for illustrative purposes and not final. Specifications will be provided when the product is launched.